• Pharma, Life Sciences Partnerships Driven By NVIDIA AI and Processors

    Apr 12 | Bio-IT World | At NVIDIA’s GTC event starting this week, NVIDIA CEO Jensen Huang outlined—among other things—partnerships expanding Clara Discovery, NVIDIA’s computational platform for healthcare. More

  • Collaboration Is Key to Combatting Cybercrime

    Apr 09 | Bio-IT World | Cybersecurity challenges have only escalated during the COVID-19 crisis, particularly in the fields of science and healthcare. The past year has seen a dramatic increase in the number of breaches and ransomware attacks for the enterprise networks of labs and healthcare facilities. More

  • Drugs Repurposed To Tap Immune System In Fight Against Pathogens

    Apr 06 | Bio-IT World | Researchers at the University of California (UC), San Diego have proposed that the definition of antibiotic resistance be broadened to include treatment failure among patients on appropriate antibiotic therapy, which still encompasses the “great majority of unsuccessful outcomes in infectious disease. More

  • Follow the Money: Single-Cell Multiomics, Data Networks, Security

    Apr 01 | Bio-IT World | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand. More

  • Viruses (And People) Play A ‘Signaling Game’ With Strangers And Dangers

    Mar 31 | Bio-IT World | Mathematically speaking, the cytokine storm seen with severe COVID-19 and the out-of-control behavior of QAnon conspiracy theorists are not really all that different, according to Bud Mishra, a professor at New York University's Courant Institute of Mathematical Sciences. Both invoke a stranger-danger “signaling game” that would also explain how messenger RNA (mRNA) and transfer RNA (tRNA) came to be cellular co-occupants some three and half billion years ago. More

  • Global Research Spanning 30+ Countries to Examine COVID’s Impact on the Brain

    Mar 30 | Bio-IT World | While it isn’t clear just yet how the coronavirus could impact cognition over the long haul, a global group of researchers is looking to learn more. More

  • 5 Important AI Discoveries Generated by COVID-19

    Mar 26 | Bio-IT World | Life sciences leaders are outlining the learnings from COVID-19 to move forward, hopefully stronger, wiser, and better than before. More

  • New Framework For Developing Polygenic Risk Scores

    Mar 25 | Bio-IT World | Last week a research team published a 22-item framework in Nature that identifies the minimal polygenic risk score-related information that scientists should include in their studies. More

  • Eric Dishman on Paul Allen, Andy Grove, and All of Us

    Mar 23 | Bio-IT World | TRENDS FROM THE TRENCHES—It’s been a little over a year since Eric Dishman stepped down as CEO of the National Institutes of Health’s All of Us program and took on the role of Chief Innovation Officer. Now he talks about his early training under Paul Allen of Microsoft and Andy Grove of Intel still plays into his decisions. More

  • Jay Flatley Steps Down From Illumina Board

    Mar 18 | Bio-IT World | Illumina has announced that Jay Flatley has decided to step down from the Board of Directors and John W. Thompson will be appointed as the Company’s new Chair of the Board. These changes will be effective as of the Company’s Annual Shareholder Meeting on May 26, 2021. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight

Digital Therapeutics: Taking digital health to a new level
Benchling is the most widely-adopted life sciences R&D cloud. Accelerate, measure, and forecast R&D – from discovery through bioprocessing – all in one place. It’s a fully unified platform that centralizes and standardizes all R&D data, so you can spend less time fighting with legacy software, and more time reaching breakthrough discoveries.
Read more here!